These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9489608)

  • 21. Berberine protects C57BL/6J mice against ethanol withdrawal-induced hyperexcitability.
    Bhutada P; Mundhada Y; Bansod K; Hiware R; Rathod S; Dixit P; Mundhada D
    Phytother Res; 2011 Feb; 25(2):302-7. PubMed ID: 20734325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Self-reported sleep, sleepiness, and repeated alcohol withdrawals: a randomized, double blind, controlled comparison of lorazepam vs gabapentin.
    Malcolm R; Myrick LH; Veatch LM; Boyle E; Randall PK
    J Clin Sleep Med; 2007 Feb; 3(1):24-32. PubMed ID: 17557449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different actions of gabapentin and baclofen in hippocampus from weaver mice.
    Bertrand S; Morin F; Lacaille JC
    Hippocampus; 2003; 13(4):525-8. PubMed ID: 12836919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of alcohol withdrawal syndrome with gabapentin.
    Bonnet U; Banger M; Leweke FM; Maschke M; Kowalski T; Gastpar M
    Pharmacopsychiatry; 1999 May; 32(3):107-9. PubMed ID: 10463378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased NMDA receptor and calcium channel activity underlying ethanol withdrawal hyperexcitability.
    Whittington MA; Lambert JD; Little HJ
    Alcohol Alcohol; 1995 Jan; 30(1):105-14. PubMed ID: 7748267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for a causative role of N-methyl-D-aspartate receptors in an in vitro model of alcohol withdrawal hyperexcitability.
    Thomas MP; Monaghan DT; Morrisett RA
    J Pharmacol Exp Ther; 1998 Oct; 287(1):87-97. PubMed ID: 9765326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gabapentin actions on Kir3 currents and N-type Ca2+ channels via GABAB receptors in hippocampal pyramidal cells.
    Bertrand S; Nouel D; Morin F; Nagy F; Lacaille JC
    Synapse; 2003 Nov; 50(2):95-109. PubMed ID: 12923812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic dihydropyridine treatment can reverse the behavioural consequences of and prevent adaptations to, chronic ethanol treatment.
    Whittington MA; Dolin SJ; Patch TL; Siarey RJ; Butterworth AR; Little HJ
    Br J Pharmacol; 1991 Jul; 103(3):1669-76. PubMed ID: 1834295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of dihydropyridine calcium channel antagonists in ethanol withdrawal; doses required, stereospecificity and actions of Bay K 8644.
    Littleton JM; Little HJ; Whittington MA
    Psychopharmacology (Berl); 1990; 100(3):387-92. PubMed ID: 1690434
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation between increases in dihydropyridine binding in vivo and behavioural signs of ethanol withdrawal in mice.
    Watson WP; Little HJ
    Alcohol Alcohol; 1999; 34(1):35-42. PubMed ID: 10075399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gabapentin potentiation of the antiepileptic efficacy of vigabatrin in an in vitro model of epilepsy.
    Lücke A; Musshoff U; Köhling R; Osterfeld M; Mayer T; Wolf P; Schütte W; Speckmann EJ
    Br J Pharmacol; 1998 May; 124(2):370-6. PubMed ID: 9641555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The anxiolytic etifoxine protects against convulsant and anxiogenic aspects of the alcohol withdrawal syndrome in mice.
    Verleye M; Heulard I; Gillardin JM
    Alcohol; 2009 May; 43(3):197-206. PubMed ID: 19393860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ethanol tolerance and withdrawal responses in GABA(A) receptor alpha 6 subunit null allele mice and in inbred C57BL/6J and strain 129/SvJ mice.
    Homanics GE; Le NQ; Kist F; Mihalek R; Hart AR; Quinlan JJ
    Alcohol Clin Exp Res; 1998 Feb; 22(1):259-65. PubMed ID: 9514316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic intermittent ethanol exposure enhances NMDA-receptor-mediated synaptic responses and NMDA receptor expression in hippocampal CA1 region.
    Nelson TE; Ur CL; Gruol DL
    Brain Res; 2005 Jun; 1048(1-2):69-79. PubMed ID: 15919065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hippocampal CA1 region neurodegeneration produced by ethanol withdrawal requires activation of intrinsic polysynaptic hippocampal pathways and function of N-methyl-D-aspartate receptors.
    Prendergast MA; Harris BR; Mullholland PJ; Blanchard JA; Gibson DA; Holley RC; Littleton JM
    Neuroscience; 2004; 124(4):869-77. PubMed ID: 15026127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Input resistance is voltage dependent due to activation of Ih channels in rat CA1 pyramidal cells.
    Surges R; Freiman TM; Feuerstein TJ
    J Neurosci Res; 2004 May; 76(4):475-80. PubMed ID: 15114619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leuprolide: a luteinizing hormone releasing hormone agonist attenuates ethanol withdrawal syndrome and ethanol-induced locomotor sensitization in mice.
    Umathe SN; Bhutada PS; Dixit PV; Jain NS
    Neuropeptides; 2008 Jun; 42(3):345-53. PubMed ID: 18280564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Ro 15-4513 and nifedipine on the behaviour and potassium-evoked calcium uptake following withdrawal from chronic ethanol administration in rats.
    Zharkovsky A; Cebers G
    Alcohol Alcohol Suppl; 1993; 2():483-7. PubMed ID: 7748343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered pharmacology of synaptic and extrasynaptic GABAA receptors on CA1 hippocampal neurons is consistent with subunit changes in a model of alcohol withdrawal and dependence.
    Liang J; Cagetti E; Olsen RW; Spigelman I
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1234-45. PubMed ID: 15126642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The neurotoxicity induced by ethanol withdrawal in mature organotypic hippocampal slices might involve cross-talk between metabotropic glutamate type 5 receptors and N-methyl-D-aspartate receptors.
    Harris BR; Gibson DA; Prendergast MA; Blanchard JA; Holley RC; Hart SR; Scotland RL; Foster TC; Pedigo NW; Littleton JM
    Alcohol Clin Exp Res; 2003 Nov; 27(11):1724-35. PubMed ID: 14634487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.